Please assess the completion status of the following clinical trial:

Trial Title: Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Children between 1 year and 18 years of age.~* The presence of documented venous or arterial thrombosis confirmed by diagnostic imaging.~* Weight greater than 8.3 kg.~* Signed informed consent/assent.~Exclusion Criteria:~* Patients with active bleeding.~* Patients with planned invasive procedures less than 2 weeks from the time of enrollment.~* Patients with a contraindication to anticoagulation.~* Patients receiving thrombolytic agents.~* Patients with an INR\>1.5 or an activated partial thromboplastin time (PTT)\>40 seconds.~* Patients with a creatinine level above 1.2 times the upper limit of normal expected for age.~* Children \<1 year of age.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 18 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).